Exelixis (EXEL) Gets a Hold from Wells Fargo

In a report released today, from Wells Fargo maintained a Hold rating on Exelixis, with a price target of $40.00.

Claim 55% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In addition to Wells Fargo, Exelixis also received a Hold from Barclays’s Etzer Darout in a report issued today. However, on the same day, William Blair reiterated a Buy rating on Exelixis (NASDAQ: EXEL).

Based on Exelixis’ latest earnings release for the quarter ending January 2, the company reported a quarterly revenue of $598.66 million and a net profit of $244.53 million. In comparison, last year the company earned a revenue of $566.76 million and had a net profit of $139.86 million

Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EXEL in relation to earlier this year. Most recently, in February 2026, Aftab Dana, the EVP, Research and Development of EXEL sold 47,918.00 shares for a total of $2,132,351.00.